Reed Elsevier Given New $12.24 Price Target at UBS AG (REL)
Research analysts at UBS AG lifted their target price on shares of Reed Elsevier (LON: REL) from $11.93 (770 GBX) to $12.24 (790 GBX) in a report released on Wednesday. The firm currently has a “buy” rating on the stock.
Shares of Reed Elsevier traded up 0.21% during mid-day trading on Wednesday, hitting GBX 715.50. Reed Elsevier has a 52 week low of GBX 466.10 and a 52 week high of GBX 714.50. The stock’s 50-day moving average is currently GBX 599.8. The company’s market cap is £8.615 billion.
A number of other firms have also recently commented on REL. Analysts at Numis Securities Ltd reiterated an “add” rating on shares of Reed Elsevier in a research note to investors on Tuesday. They now have a $12.43 price target on the stock. Separately, analysts at HSBC downgraded shares of Reed Elsevier from an “overweight” rating to a “neutral” rating in a research note to investors on Tuesday, February 12th. They now have a $11.27 price target on the stock, up previously from $10.57. Finally, analysts at Liberum Capital reiterated a “buy” rating on shares of Reed Elsevier in a research note to investors on Thursday, January 31st. They now have a $11.06 price target on the stock.
Reed Elsevier PLC is a provider of professional information solutions. As of December 31, 2011, the Company was organized in five business segments: Elsevier, providing scientific, technical and medical information solutions; LexisNexis Risk Solutions, providing risk information and analytics to business and government customers; LexisNexis Legal & Professional, providing legal, tax, regulatory and business information solutions to professionals, business and government customers; Reed Exhibitions, organising trade exhibitions and conferences, and Reed Business Information, providing information and marketing solutions to business professionals.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.